Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Related Citations for PubMed (Select 22231044)

1.

Are we ready for online tools in decision making for BRCA1/2 mutation carriers?

Evans DG, Howell A.

J Clin Oncol. 2012 Feb 10;30(5):471-3. doi: 10.1200/JCO.2011.40.1562. Epub 2012 Jan 9. No abstract available.

2.

Online tool to guide decisions for BRCA1/2 mutation carriers.

Kurian AW, Munoz DF, Rust P, Schackmann EA, Smith M, Clarke L, Mills MA, Plevritis SK.

J Clin Oncol. 2012 Feb 10;30(5):497-506. doi: 10.1200/JCO.2011.38.6060. Epub 2012 Jan 9.

3.

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.

Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M, Foulkes WD, Ghadirian P, Lynch H, Couch F, Wong J, Wright F, Sun P, Narod SA.

J Clin Oncol. 2011 May 1;29(13):1664-9. doi: 10.1200/JCO.2009.27.0835. Epub 2011 Mar 28.

4.

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.

Kurian AW, Sigal BM, Plevritis SK.

J Clin Oncol. 2010 Jan 10;28(2):222-31. doi: 10.1200/JCO.2009.22.7991. Epub 2009 Dec 7.

5.

Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations.

Roukos DH, Agnanti NJ, Paraskevaidis E, Kappas AM.

Ann Surg Oncol. 2002 Dec;9(10):941-3. No abstract available.

PMID:
12464584
6.

Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy.

van Roosmalen MS, Verhoef LC, Stalmeier PF, Hoogerbrugge N, van Daal WA.

J Clin Oncol. 2002 Apr 15;20(8):2092-100.

PMID:
11956270
7.

MRI in the early detection of breast cancer in women with high genetic risk.

Trecate G, Vergnaghi D, Manoukian S, Bergonzi S, Scaperrotta G, Marchesini M, Ferranti C, Peissel B, Spatti G, Bohm S, Conti A, Costa C, Sporeni M, Podo F, Musumeci R.

Tumori. 2006 Nov-Dec;92(6):517-23.

PMID:
17260493
8.

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.

Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E.

Am J Med Genet A. 2003 Apr 30;118A(3):201-9.

PMID:
12673648
9.
10.

Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.

Hartman AR, Daniel BL, Kurian AW, Mills MA, Nowels KW, Dirbas FM, Kingham KE, Chun NM, Herfkens RJ, Ford JM, Plevritis SK.

Cancer. 2004 Feb 1;100(3):479-89.

11.

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.

Anderson K, Jacobson JS, Heitjan DF, Zivin JG, Hershman D, Neugut AI, Grann VR.

Ann Intern Med. 2006 Mar 21;144(6):397-406.

PMID:
16549852
12.

Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.

Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S.

Clin Genet. 2009 Mar;75(3):220-4.

PMID:
19263514
13.

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.

Rhiem K, Foth D, Wappenschmidt B, Gevensleben H, B├╝ttner R, Ulrich U, Schmutzler RK.

Arch Gynecol Obstet. 2011 Mar;283(3):623-7. doi: 10.1007/s00404-010-1476-3. Epub 2010 Apr 29.

PMID:
20428881
14.

[Hereditary breast and ovarian cancer: primary and secondary prevention for BRCA1 and BRCA2 mutation carriers].

Llort G, Peris M, Blanco I.

Med Clin (Barc). 2007 Mar 31;128(12):468-76. Review. Spanish.

PMID:
17408542
15.

Improving surveillance and quality of life of BRCA mutation carriers.

Loman N, Borg A.

J Clin Oncol. 2010 Aug 1;28(22):e376-7. doi: 10.1200/JCO.2010.28.7334. Epub 2010 May 10. No abstract available.

16.

BRCA susceptibility genes--a review of current conservative management of BRCA mutation carriers.

Levavi H, Sabah G.

Eur J Gynaecol Oncol. 2003;24(6):463-6. Review.

PMID:
14658581
17.

The case for individualized screening recommendations for breast cancer.

Bradbury A, Olopade OI.

J Clin Oncol. 2006 Jul 20;24(21):3328-30. Epub 2006 Jun 26. No abstract available.

18.

Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.

Calderon-Margalit R, Paltiel O.

Int J Cancer. 2004 Nov 10;112(3):357-64. Review.

PMID:
15382059
19.

Comparing breast cancer risk assessment models.

Gail MH, Mai PL.

J Natl Cancer Inst. 2010 May 19;102(10):665-8. doi: 10.1093/jnci/djq141. Epub 2010 Apr 28. No abstract available.

20.

The clinical management of BRCA1 and BRCA2 mutation carriers.

Gulati AP, Domchek SM.

Curr Oncol Rep. 2008 Jan;10(1):47-53. Review.

PMID:
18366960
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk